Welcome - Register - Login - Help/FAQ - 0 items

Search Enter keywords, a title or a report id number below. In All Categories --------------------- Telecom & Computing Business & Finance Mfg & Construction Pharma & Healthcare Consumer & Retail Gov & Public Sector Energy & Transport Country Reports Company Reports --------------------- Transcripts Advanced      Select a currency for use throughout the site Australia Dollars Canada Dollars Euro Japan Yen Sweden Kroner Switzerland Francs UK Pounds US Dollars Search Results Your Search for 'Lung Cancer Drug Pipeline Update' returned 174 results - Page 1 of 9  FEATURED RESULTS Cancer Diagnostic Testing World Markets Antibody Drug Target Atlas in Oncology Drug Delivery in Cancer - Technologies, Markets and Companies Antibody drug conjugates for cancer treatment: Clinical Tria... Cancer: Basic Science and Clinical Aspects   Sort by    Date Published ASC Date Published DESC Report Price ASC Report Price DESC Rank ASC Rank DESC   Sorted by Rank Top-Bottom Lung Cancer Drug Pipeline Update 2011   Bioseeker, Feb 2011 in cancer. In addition, there are 9 (9) suspended drugs and the accumulated number of ceased drugs over the last years amount to another 188 (167) drugs. Lung Cancer Drug Pipeline Update lists all drugs Analytical Tool - Lung Cancer   Bioseeker, July 2011 Analytical Tool - Lung Cancer is a premium combo product of "Lung Cancer: A Decision Support Tool for Optimizing the Pipeline from Research To Market" and "Lung Cancer Drug Pipeline Update 2011 Lung Cancer and Non-Small Cell Lung Cancer Therapy Area Pipeline Report   Life Science Analytics, March 2011, Pages: 1729 Lung Cancer and Non-Small Cell Lung Cancer Therapy Area Pipeline Report contains detailed information on the lung cancer and non-small cell lung cancer drug pipeline. This report provides insight Non-Small-Cell Lung Cancer or Lung Cancer or Small Cell Lung Cancer Therapy Area Pipeline Report   Life Science Analytics, March 2009, Pages: 831 cancer or small cell lung cancer drug pipeline. This report provides insight into the pipeline status of non-small-cell lung cancer or lung cancer or small cell lung cancer drugs by company and by stage Spanish Lung Cancer Group - Developmental Therapeutics Review - Q4 2010   Global Markets Direct, Dec 2010, Pages: 28 ’s strategic position with total access to detailed information on its product pipeline. - Assess the growth potential of Spanish Lung Cancer Group in its therapy areas of focus. - Identify new drug targets Chinese Society of Lung Cancer - Developmental Therapeutics Review - Q4 2010   Global Markets Direct, Dec 2010, Pages: 26 milestones. - Recent updates of the Chinese Society of Lung Cancer’s pipeline in the last quarter. - Key discontinued and dormant projects. - Latest news and deals relating to the products. Reasons to buy European Lung Cancer Working Party - Developmental Therapeutics Review - Q4 2010   Global Markets Direct, Dec 2010, Pages: 26 and major milestones. - Recent updates of the European Lung Cancer Working Party’s pipeline in the last quarter. - Key discontinued and dormant projects. - Latest news and deals relating to the products Targeting Cancer Stem Cells: Therapeutic Strategies, Pipeline, Biomarkers and Opportunities 2011   BioPharm Reports (VennBio Ltd.), Jan 2011, Pages: 124 , based on new and established classes. This 2011 report gives a comprehensive update on current therapeutic and diagnostic development in this field, on the drug development pipeline and the most promising Metastatic Lung Cancer - Pipeline Review, Q2 2011   Global Markets Direct, April 2011, Pages: 68 therapeutic pipeline. This report provides information on the therapeutic development for Metastatic Lung Cancer, complete with latest updates, and special features on late-stage and discontinued projects Cancer Analysis   Espicom Business Intelligence Ltd, May 2011 savings. CANCER ANALYSIS PROVIDES: - Company Performance, Products and Research Pipelines: Regularly updated and detailed analysis of over 120 leading companies' strategy, research, products Metastatic Lung Cancer - Pipeline Review, H2 2011   Global Markets Direct, Aug 2011, Pages: 53 therapeutic pipeline. This report provides information on the therapeutic development for Metastatic Lung Cancer, complete with latest updates, and special features on late-stage and discontinued projects Analytical Tool - Protein Kinase Inhibitors in Oncology   Bioseeker, Feb 2011 - Where to Commercialize? Protein Kinase Inhibitors in Oncology: Drug Pipeline Update 2011- The Package Includes - A progress analysis on current and emerging drugs - Information on most companies active Small-Cell Lung Cancer - Pipeline Review, H1 2012   Global Markets Direct, Jan 2012, Pages: 179 therapeutic pipeline. This report provides information on the therapeutic development for Small-Cell Lung Cancer, complete with latest updates, and special features on late-stage and discontinued projects Antibody Drug Targets and Special Focus on Leukemias & Lymphomas   Bioseeker, Dec 2007, Pages: 430 by Molecular Function Classes of Targets 3(3) Figure 4: Pipeline Maturation of Carboxypeptidase Activity Targets Figure 5: Number of Antibody Drugs per Cancer Indication and Carboxypeptidase Activity Target Small-Cell Lung Cancer - Pipeline Review, Q3 2011   Global Markets Direct, July 2011, Pages: 154 therapeutic pipeline. This report provides information on the therapeutic development for Small-Cell Lung Cancer, complete with latest updates, and special features on late-stage and discontinued projects Gene Therapy - Technologies, Markets and Companies   Jain PharmaBiotech, Feb 2012, Pages: 659 adenoviral ErbB-2/neu vaccine Gene Therapy for ovarian cancer Gene therapy for malignant melanoma Gene therapy of lung cancer Intravenous nanoparticle formulation for delivery of FUS1 gene Aerosol gene Small-Cell Lung Cancer - Pipeline Review, Q1 2011   Global Markets Direct, Jan 2011, Pages: 138 therapeutic pipeline. This report provides information on the therapeutic development for Small-Cell Lung Cancer, complete with latest updates, and special features on late-stage and discontinued projects Non-Small Cell Lung Cancer - Pipeline Review, H2 2011   Global Markets Direct, Sep 2011, Pages: 605 Cancer therapeutic pipeline. This report provides information on the therapeutic development for Non-Small Cell Lung Cancer, complete with latest updates, and special features on late-stage Lung Cancer - Pipeline Review, Q1 2011   Global Markets Direct, Jan 2011, Pages: 170 Lung Cancer - Pipeline Review, Q1 2011 Summary Global Markets Direct’s, 'Lung Cancer - Pipeline Review, Q1 2011', provides an overview of the Lung Cancer therapeutic pipeline. This report provides Results:  First -   Prev -   1 -   2 -   3 -   4 -   5 -   6 -   Next -   Last

		For enquiries please call us on:   +353-1-415-1241 (GMT Office Hours)   1-800-526-8630 (US/Canada Toll Free)   1-917-300-0470 (EST Office Hours)

All rights reserved. © Copyright 2012 Research and Markets3    Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network